ReproCell Akcija

ReproCell EV/FCF

Vrijednost EV/FCF (Вредност предузећа према слободном готовинском току) od ReproCell (4978.T) na dan 26. јул 2026. je -143,10. Prethodne godine, EV/FCF (Вредност предузећа према слободном готовинском току) je bio -48,56 — promjena od 194,71% (niži).

EV/FCF

-143,10

YoY

194,71%

Zadnja ažuriranja:

EV/FCF (Вредност предузећа према слободном готовинском току) od ReproCell je 2026 -143,10 . EV/FCF (Вредност предузећа према слободном готовинском току) od ReproCell je bio 2025 -48,56 . Pad je time 194,71% niži u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

ReproCell Анализа акција

Šta radi ReproCell? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji ReproCell

EV/FCF (Вредност предузећа према слободном готовинском току) kompanije ReproCell iznosi -143,10 u 2026. godini.

Access this data via the Eulerpool API

Вредновање — ReproCell

Sve ključne metrike — ReproCell

Раст